Table 3.
Changes in anemia control measures in treatment and control groups
| Treatment group, baseline | End of the study (n = 22) | Control group, baseline | End of the study (n = 22) | |
|---|---|---|---|---|
| Hb concentration (g/dL) | 10.85 ± 1.31 | 11.25 ± 1.1 | 11.05 ± 0.74 | 11.43 ± 0.9 |
| Erythropoietin doses (IU/week) | 6363.64 ± 3244.71 | 5000.00a ± 2943.92 | 5727.27 ± 3224.63 | 4681.82 ± 3045.47 |
| Erythropoietin resistance index (IU/kg per week per g/dL) | 9.93 ± 7.35 | 7.46a ± 5.59 | 8.23 ± 4.84 | 6.62 ± 4.31 |
| Serum iron (μg/dL) | 76.09 ± 17.15 | 78.02 ± 34.65 | 88.38 ± 44.78 | 86.75 ± 32.64 |
| Total iron binding capacity (TIBC) (μg/dL) | 324.2 ± 107.9 | 280.5 ± 117.7 | 325.9 ± 88.6 | 311.1 ± 112.0 |
| Transferrin saturation (TSAT) (%) | 26.53 ± 11.87 | 29.87 ± 11.34 | 27.54 ± 10.59 | 30.02 ± 12.29 |
| Ferritin (ng/mL) | 563.60 ± 351.96 | 536.64 ± 310.16 | 706.46 ± 451.30 | 641.05 ± 393.06 |
Notes: Values expressed as mean ± SD.
a
P < 0.05 compared with baseline.
Abbreviations: Hb, hemoglobin; IU, international units; TIBC, total iron binding capacity; TSAT, transferrin saturation; SD, standard deviation.